2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents

Details for Australian Patent Application No. 2005322439 (hide)

Owner Emergent Immunosolutions

Inventors Tomazic, Alenka; Wang, Weitong; Clancy, Joanna; Huang, Liren; Taylor, Christopher; Jackson, James W.

Agent Griffith Hack

Pub. Number AU-A-2005322439

PCT Pub. Number WO2006/071471

Priority 60/634,085 08.12.04 US

Filing date 7 December 2005

Wipo publication date 6 July 2006

International Classifications

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/071471 Priority application(s): WO2006/071471

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322445-Radio frequency identification device with visual indicator

2005322435-Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders